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Summary
 
We have isolated CD8
 
1
 
 
 
a
 
/
 
b
 
 T cells from the blood of atopic and healthy individuals which
recognize a nonpeptide antigen present in an allergenic extract from 
 
Parietaria judaica
 
 pollen.
This antigen appears to be a carbohydrate because it is resistant to proteinase K and alkaline di-
gestion, is hydrophilic, and is sensitive to trifluoromethane-sulphonic and periodic acids. In ad-
dition, on a reverse-phase high performance liquid chromatography column the antigen recog-
nized by CD8
 
1
 
 T cells separates in a fraction which contains 
 
.
 
80% hexoses (glucose and
galactose) and undetectable amounts of proteins. Presentation of this putative carbohydrate an-
tigen (Pj
 
CHO
 
Ag) to CD8
 
1
 
 T cell clones is dependent on live antigen presenting cells (APCs)
pulsed for 
 
.
 
1 h at 37
 
8
 
C, suggesting that the antigen has to be internalized and possibly pro-
cessed. Indeed, fixed APCs or APCs pulsed at 15
 
8
 
C were both unable to induce T cell re-
sponse. Remarkably, Pj
 
CHO
 
Ag presentation is independent of the expression of classical major
histocompatibility complex (MHC) molecules or CD1. CD8
 
1
 
 T cells stimulated by Pj
 
CHO
 
Ag-
pulsed APCs undergo a sustained [Ca
 
2
 
1
 
]
 
i
 
 increase and downregulate their T cell antigen recep-
tors (TCRs) in an antigen dose– and time-dependent fashion, similar to T cells stimulated by
conventional ligands. Analysis of TCR V
 
b
 
 transcripts shows that six independent Pj
 
CHO
 
Ag-
specific T cell clones carry the V
 
b
 
8 segment with a conserved motif in the CDR3 region, indi-
cating a structural requirement for recognition of this antigen. Finally, after activation, the
CD8
 
1
 
 clones from the atopic patient express CD40L and produce high levels of interleukins 4
and 5, suggesting that the clones may have undergone a Th2-like polarization in vivo. These
results reveal a new class of antigens which triggers T cells in an MHC-independent way, and
these antigens appear to be carbohydrates. We suggest that this type of antigen may play a role
in the immune response in vivo.
 
I
 
t is well known that T lymphocytes expressing 
 
a
 
/
 
b
 
TCR recognize antigenic peptide bound to MHC mole-
cules. However, there is increasing evidence that nonpro-
tein antigens can also be recognized by T cells (for review
see reference 1). A first category of nonprotein antigens is
represented by lipids or glycolipids such as mycolic acid
and lipoarabinomannan (2–4). Presentation of these anti-
gens to 
 
a
 
/
 
b
 
 T cells requires processing and is carried out
by CD1 molecules which display a specificity for hydro-
phobic antigens (1). A second class of nonprotein antigens
includes low mol wt phosphorylated molecules such as iso-
pentenyl pyrophosphate and its synthetic analogs (5–7). In
this case presentation to 
 
g
 
/
 
d
 
 T cells is independent from
uptake and processing and does not require any known an-
tigen presenting molecule.
A long-standing question is whether carbohydrates may
be recognized by T cells. It has been shown that MHC
molecules can bind glycopeptides via the peptide moiety
and display the carbohydrate for interaction with TCR
(8–11). However, this type of recognition still can be re-
garded as a variation of conventional peptide antigen rec-
ognition as it has been shown for haptenized peptide (12).
So far, there has been neither evidence that carbohydrates
may bind directly to MHC or other antigen presenting
molecules (13, 14) nor reports that carbohydrates as such
might trigger T cells in the absence of MHC molecules.
We have observed that T cells which proliferate in vitro
 
S. Corinti and R. De Palma contributed equally to this work.
 
Maria Cristina Gagliardi,* Carlo Pini,* and Federica Sallusto* 
900
 
MHC-independent Recognition of a Pollen Antigen by
 
 a
 
/
 
b
 
 T Cells
 
in response to a pollen extract from 
 
Parietaria judaica
 
 (PjE)
 
1
 
,
a common environmental allergen of the Mediterranean
area (15), comprise a sizable fraction of CD8
 
1
 
 
 
a
 
/
 
b
 
 T cells.
Here we provide evidence that these T cells recognize a
putative carbohydrate antigen present in PjE. Presentation
of Pj
 
CHO
 
Ag to T cells is dependent on APCs, but is not re-
stricted by either MHC or CD1 molecules. These results
reveal a new mode of antigen presentation and a new class
of ligands which can trigger 
 
a
 
/
 
b
 
 T cells.
 
Materials and Methods
 
PjE Reactive T Cell Clones.
 
PBMCs from one atopic and one
healthy individual were cultured in 96-well flat-bottomed plates
(Costar Corp., Cambridge, MA) in RPMI 1640 supplemented
with 2 mM 
 
l
 
-glutamine, 1% nonessential amino acids, 1% pyru-
vate, 50 
 
m
 
g/ml kanamycin, 5 
 
3
 
 10
 
2
 
5
 
 M 2-ME (GIBCO BRL,
Gaithersburg, MD) and 5% human serum (Sigma Chemical Co.,
St. Louis, MO) in the presence of PjE (50 
 
m
 
g protein/ml). Re-
combinant IL-2 (20 U/ml; provided by Dr. A. Lanzavecchia,
Basel Institute for Immunology, Basel, Switzerland) was added at
day 6. After 20 d, T cell blasts were cloned by limiting dilution. T
cell clones were maintained by periodic restimulation with phy-
tohemagglutinin, irradiated allogeneic PBMCs (3,000 rad from a
 
60
 
Co source), and rIL-2 as previously described (16).
 
Cell Lines.
 
Dendritic cells (DCs) were generated by culturing
peripheral blood monocytes in the presence of GM-CSF and IL-4
(17). T2 (TAP-deficient), and 221 (class I–deficient) were pro-
vided by Dr. A. Lanzavecchia. SJO (class II–deficient) was a gift
of Dr. J. Gorsky (Blood Research Institute, Milwaukee, WI).
C1R (class I–deficient) stably transfected with the CD1a, CD1b,
or CD1c genes or mock transfected were provided by Dr. M.
Brenner (Brigham and Women’s Hospital, Boston, MA). EBV-
transformed lymphoblastoid cell lines (B-LCL) were derived from
PBMCs as described (18). All cell lines were maintained in 10%
FCS-RPMI (Hyclone Labs., Inc., Logan, UT).
 
FACS
 
Ò
 
 Analysis.
 
Cell staining was performed using mouse
mAbs followed by FITC- or PE-conjugated affinity-purified, iso-
type specific goat anti–mouse antibodies (Southern Biotechnol-
ogy Associates, Inc., Birmingham, AL). The following antibodies
were used: OKT8 (IgG2a, anti-CD8; American Tissue Culture
Collection, Rockville, MD), 6D10 (IgG1, anti-CD4; provided
by Dr. E. Roosnek, University of Geneva, Geneva, Switzerland);
PE-Leu2a (IgG1, anti-CD8; Becton Dickinson, Mountain View,
CA); FITC–anti-TCR 
 
a
 
/
 
b
 
 (IgG1; Becton Dickinson); B1
(IgG1, anti–pan-
 
g
 
/
 
d
 
, provided by Dr. G. De Libero, University
of Basel, Basel, Switzerland); a panel of mAbs recognizing differ-
ent V
 
b
 
 gene products (Immunotech, Marseille, France); and
TRAP-1 (IgG1, anti-hCD40L; provided by Dr. R. Kroczek,
University of Berlin, Berlin, Germany). The samples were ana-
lyzed on a FACScan
 
Ò
 
 using propidium iodide to exclude dead
cells.
 
Antigen Presentation Assay.
 
T cells were cultured with APC in
the presence of various concentrations of antigens in 200 
 
m
 
l hu-
man serum–RPMI in flat-bottomed microplates. Cultures were
pulsed with 1 
 
m
 
Ci of [
 
3
 
H]thymidine (2 Ci/mmol; Amersham In-
ternational, Little Chalfont, UK) on day 2 and harvested 16 h
later. For antibody blocking studies, cultures were carried out in
the presence of different antibodies provided as 1:10 dilution of
culture supernatant. The following mAbs were used: W6/32
(IgG2a, anti–HLA class I), L243 (IgG2a, anti–HLA-DR), SPVL3
(IgG2a, anti–HLA-DQ), and B7/21 (IgG1, anti–HLA-DP).
APCs were either irradiated or treated with 1 mg/ml mitomycin
C (Sigma Chemical Co.) for 30 min at 37
 
8
 
C. In some experi-
ments the APC were fixed with 0.05% glutaraldehyde for 30 s
and blocked with 0.1 M lysine in PBS for 5 min before or after
antigen pulse.
 
Cytokine Production.
 
T cells were stimulated for 40 h with
10
 
2
 
7
 
 M PMA (Sigma Chemical Co.) and anti-CD3 antibody
(TR66, 0.2 
 
m
 
g/ml). Cytokine production was quantified in the
supernatants by ELISA (PharMingen, San Diego, CA; reference 19).
 
Preparation of PjE and Removal of Proteins, Phosphates, and Carbo-
hydrates.
 
PjE was prepared by extracting PjE pollen (Allergon,
Angelholm, Sweden) with 0.125 M bicarbonate buffer as de-
scribed (20). The extract contained 
 
z
 
20% protein as assessed by
the Bradford method (21). PjE was also purchased from Neo-
Abello (Madrid, Spain). To remove proteins from the extract two
methods were used. First, 5 mg PjE was digested in 200 
 
m
 
l PBS,
pH 7.2, with 100 
 
m
 
g proteinase K (PK; Sigma Chemical Co.) in
the presence of 1 mM CaCl
 
2
 
 for 2 h at 37
 
8
 
C followed by heating
at 65
 
8
 
C for 5 min. The digestion was repeated twice. Alterna-
tively, 5 mg PjE was incubated in 100 
 
m
 
l 3 M NaOH/0.1 M
NaBH
 
4
 
 overnight at room temperature. The samples (referred to
as 
 
PK
 
PjE and 
 
NaOH
 
PjE, respectively) were tested and compared to
the same concentration of untreated or mock-treated PjE. To re-
move phosphates, PjE (2.5 mg) was treated with 10 U phos-
phatase A (Sigma Chemical Co.) in 100 
 
m
 
l of 50 
 
m
 
M Tris/HCl,
pH 8.3, for 2 h at 37
 
8
 
C. The enzyme was inactivated by heating
to 65
 
8
 
C for 10 min. To remove sugars two methods were used.
PjE (10 mg) was treated for 1 h at 0
 
8
 
C with trifluoromethane-sul-
phonic acid (TFMS) and anisole (1:2 ratio) as described (22). Af-
ter incubation, an equal volume of ice-cold aqueous pyridine
(60% vol/vol) was added. Alternatively, PjE (5 mg/ml) was incu-
bated in 10 mM acetate buffer, pH 4.7, containing 10 mM so-
dium periodate (SP; Sigma Chemical Co.) for 6 h at 4
 
8
 
C in the
dark (23). The reaction was stopped with a molar excess of ethyl-
ene glycol and NaBH
 
4
 
 was added at 2 mg/ml. The samples (re-
ferred to as 
 
TFMS
 
PjE and 
 
SP
 
PjE, respectively) were tested and com-
pared to the same concentration of untreated or mock-treated PjE.
 
Purification of the Antigen Recognized by CD8
 
1
 
 T Cell Clones.
 
The antigen recognized by CD8
 
1
 
 T cell clones was purified from
crude pollen extract using two different protocols. In the first
protocol, PjE was dissolved in 4% trichloroacetic acid (15 mg/ml)
and precipitated proteins were removed by centrifugation. The
supernatant was neutralized by 1 N NaOH and lyophilized. The
sample was fractionated on a preparative reverse-phase column
(RP-8; Waters, Millipore Corporation, Bedford, MA) by eluting
with a linear gradient of methanol in water. Collected fractions
were concentrated at reduced pressure, lyophilized, and tested for
biological activity as well as for carbohydrate and protein content.
In the second protocol, PjE (300 mg in 80 ml water) was ex-
tracted (80:65, vol/vol aqueous to organic) with chloroform/
methanol (2:1, vol/vol) and the two phases were separated by
centrifugation. The upper layer and the interface were recovered
and lyophilized, and the lower layer was dried under nitrogen.
Most of the biological activity was found in the upper fraction.
The water soluble material (92 mg) was dissolved in 12 ml water
and separated using two cycles of centrifugal concentrators with a
cutoff of 10 and 3 kD (Amicon Inc., Beverly, MA). The biologi-
 
1
 
Abbreviations used in this paper:
 
 B-LCL, EBV-transformed lymphoblastoid
cell lines; DC, dendritic cell; GC-MS, gas chromatography–mass spec-
trometry; PjCHOAg, carbohydrate antigen present in PjE; PjE, 
 
Parietaria
judaica
 
 pollen extract; rpHPLC, reverse-phase HPLC; SP, sodium perio-
date; TFMS, trifluoromethane-sulphonic acid. 
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cal activity was recovered in the filtrate of the 10-kD concentra-
tor and was only partially retained in the 3-kD concentrator. The
3-kD filtrate was lyophilized to give 11 mg residue. This was fur-
ther fractionated on a reverse phase HPLC (rpHPLC; RP-18;
Waters) by eluting with a gradient of methanol in water. The
fractions were tested for biological activity as well as for carbohy-
drate and protein content. The sugar content in the chromato-
graphic fractions was measured according to Ashwell (24).
Briefly, 0.1 mg of the lyophilizate was dissolved in 2 ml water and
treated with 0.05 ml phenol reagent (80% by weight of redistilled
phenol in water) and 5 ml of concentrated sulfuric acid. The sam-
ple was kept at room temperature for 30 min and the optical den-
sity was determined at 490 nm. The amount of carbohydrate
content was estimated by comparison to a standard curve of glu-
cose. The protein content was determined by a protein assay
(Bio-Rad, Hercules, CA) using BSA as standard.
 
Sugar Analysis on Active Antigenic Fractions.
 
Samples from the
active chromatographic fractions were hydrolyzed with 2 M TFA
followed by reduction with NaBH
 
4
 
 to give a mixture of alditols.
Such compounds were acetylated by acetic anhydride and pyri-
dine to yield a mixture of alditol acetates, which were analyzed by
gas chromatography–mass spectrometry (GC-MS). To exclude the
interference of free monosaccharides, a mock control was per-
formed after acetylation of an untreated aliquot of the samples.
 
[Ca
 
2
 
1
 
]
 
i
 
 Measurement.
 
T cell clones were loaded with Indo-1
AM (Sigma Chemical Co.) as described (25). Cells were mixed at
a 1:2 ratio with autologous B-LCL cells which had been pulsed
with PjE or 
 
NaOH
 
PjE. The cells were centrifuged at 1,500 rpm for
1 min at 4
 
8
 
C to allow conjugate formation, heated for 1 min at
37
 
8
 
C, and analyzed on a Coulter Elite Flow Cytometer (Coulter
Electronics Inc., Hialeah, FL) to detect Ca
 
2
 
1
 
 fluxes in conjugated
T cells (25). Only live (based on forward and side scatter criteria)
and Indo-1–loaded cells were included in the analysis. As positive
control we recorded Ca
 
2
 
1
 
 fluxes in T cells after cross-linking of
CD3 with a specific mAb (clone TR66).
V b8 TCR-CDR3 Sequencing. Three clones from the atopic
patient and three clones from the normal control were further an-
alyzed by CDR3 spectratyping as previously described (26). Once
it was proved that the clones contained only one genomic se-
quence, direct sequencing was performed. The cDNA obtained
from the relevant clones was amplified for the Vb8 TCR family
according to a published procedure (27). The Vb8-specific PCR
products were purified by means of a Microspin G50 column
(Pharmacia Biotech, Uppsala, Sweden) to eliminate unincorpo-
rated primers. After purification 0.5-ml PCR products were used
for cycle sequencing reaction according to instructions (Perkin-
Elmer, Pasadena, CA) using sense and antisense internal primers
in different PCR reactions. After amplification the samples were
dried, boiled for 2 min in 4 ml loading dye, and then loaded on a
fluorescence based sequencer (ABI373, Perkin-Elmer) using a de-
naturing 40% acrylamide gel. The samples were run for 8 h and
the data were collected and analyzed using a 373 sequencing soft-
ware for base calling.
Results
Isolation of CD81 T Cell Clones Specific for PjE. PBMCs
from a PjE-sensitive patient and one nonatopic individual
were stimulated in vitro with PjE. The responding cells
were expanded with IL-2. After 20 d the cell lines were
enriched for antigen-specific T cells as shown by a strong
proliferative response to the inducing agent in the presence
of autologous mononuclear cells (data not shown). Inter-
estingly, in several independent cell lines from both indi-
viduals a sizable fraction of the T cells (20–30%) was CD81
(Fig. 1 A). Since it is unusual to find CD81 T cells in cul-
tures stimulated by protein antigens, we isolated a number
of CD41 and CD81 a/b T cell clones (Fig. 1 B) by limit-
ing dilution and tested their capacity to recognize PjE.
As shown in Table 1, several CD81 T cell clones isolated
from the atopic patient and the healthy individual prolifer-
ated in response to PjE. Proliferation was specific since it
was observed using different sources of PjE, while pollen
extracts from unrelated species such as Cupressus arizonica
and Olea europaea were ineffective (not shown). Interest-
ingly, while CD81 clones from the healthy control pro-
duced only IFN-g, those isolated from the allergic patient
produced high levels of IL-4 and IL-5 (Table 1) and ex-
pressed CD40L after stimulation (Fig. 1 C), suggesting that
they may have undergone a Th2-like polarization in vivo.
a/b1 CD81 T Cell Clones Recognize a Proteinase K–resis-
tant, Phosphatase-resistant, Periodate-sensitive Antigen. The na-
ture of the antigen recognized by CD81 PjE-specific T cell
clones was investigated. The crude pollen extract was di-
gested with proteinase K or subjected to alkaline hydroly-
Figure 1. (A) CD4 and CD8
expression in a short-term PjE-
reactive T cell line from atopic
donor. PBMCs were stimulated
in vitro with PjE. After 20 d T
cell blasts were stained with anti-
CD8 and anti-CD4 mAbs. (B)
PjE-specific CD81 T cell clones
express a/b TCR. Clone P4.2
was stained with PE-labeled anti-
CD8 and FITC-labeled TCR-
a/b mAbs. (C) Expression of
CD40L by CD81 T cell clones.
Clone P4.2 was activated with
PMA 1 ionomycin for 8 h and
stained with anti-CD40L mAb.
Stimulated cells (filled histogram)
were compared with unstimu-
lated cells (open histogram).902 MHC-independent Recognition of a Pollen Antigen by a/b T Cells
sis. Both treatments destroyed proteins and abolished stim-
ulation of PjE-specific CD41 T cells, but did not affect and
actually enhanced stimulation of the CD81 clones, suggest-
ing that CD81 T cells recognize a nonprotein antigen (Fig.
2). Treatment with alkaline phosphatase did not decrease
the capacity of PjE to stimulate CD81 clones, indicating
that the antigen does not contain critical phosphate residues
(data not shown). When PjE was extracted with chloro-
form/methanol, the antigen recognized by CD81 T cells
separated in the aqueous phase (see below). Taken to-
gether, these properties suggested that the antigen recog-
nized might be a carbohydrate. Therefore, we tested the
sensitivity of the antigen to treatments which destroy sug-
ars. In contrast to protease and phosphatase treatments,
both periodic acid and TFMS treatment of PjE completely
abolished recognition by CD81 T cell clones, while the ca-
pacity to stimulate CD41 T cell clones was not affected
(Fig. 3). These results suggest that the antigen recognized
by CD81 T cell clones is not affected by removal of pro-
teins or phosphate groups but is sensitive to treatment
which degrades carbohydrates or related polyhydrate com-
pounds.
Partial Purification of the Antigen Recognized by CD81 T
Cell Clones. In a first attempt to purify the antigen recog-
nized by CD81 T cell clones, we separated the material re-
maining after protein precipitation by a semipreparative re-
verse-phase column. The activity was recovered in several
fractions and the most active was enriched in carbohydrates
(83%) but still contained z1% proteins (data not shown).
In a second attempt, we combined phase fractionation with
ultrafiltration and rpHPLC. After extraction with chloro-
form/methanol, the antigen recognized by CD81 clones
separated in the aqueous phase, which contains mainly po-
lar molecules, but was absent at the interface and in the or-
Table 1. Proliferative Response and Cytokine Profile of PjE-specific CD81 T Cell Clones from Atopic (A) and Nonatopic (B) Individuals
3H-TdR IL-4 IL-5 IFN-g 3H-TdR IL-4 IL-5 IFN-g
cpm 3 1023 pg/ml pg/ml pg/ml cpm 3 1023 pg/ml pg/ml pg/ml
Donor A Donor B
P4.2 30.5* 537‡ 746‡ .4,000* CP.27 23.4 ,20 ,20 2,395
P4.4 23.5 ,20 ,20 .4,000 CP.28 18.7 35 ,20 .4,000
P4.6 33.9 222 959 .4,000 CP.31 14.6 ,20 ,20 3,000
P4.15 27.3 356 ,20 .4,000 CP.38 25.6 ,20 ,20 2,610
P4.16 23.9 232 ,20 2,821 CP.44 10.7 ND ND ND
P4.17 42.3 80 543 .4,000 CP.45 7.4 ND ND ND
P4.26 44.3 1,378 1,300 3,394 CP.53 26.0 ND ND ND
P4.27 29.0 664 319 .4,000 CP.56 10.0 ND ND ND
P4.33 30.3 518 .2,000 2,624 CP.66 27.8 ,20 ,20 .4,000
P4.52 36.1 162 ,20 3,359 CP.68 69.2 102 ,20 .4,000
*T cells were cultured with PjE (50 mg/ml) and autologous B-LCL. Proliferative response was measured on day 3. Background response in the ab-
sence of antigen for all clones was ,1023.
‡T cells were stimulated with 1027 M PMA 1 0.2 mg/ml mAb TR66 (anti-CD3). After 40 h supernatants were collected and tested for cytokines by
ELISA.
Figure 2. CD81 T cell clones recognize a proteinase K (PK)–resistant,
alkaline-resistant antigen of PjE. CD81 T cell clones P4.2 (A) and CP.68
(C) and CD41 T cell clones P6.2 (B) and CP.39 (D) were stimulated with
autologous irradiated B-LCL in the presence of different concentration of
PjE (h), PKPjE (d), or NaOHPjE (j). A mock control for proteinase K (s)
was also included. Proliferative response was measured on day 3. Diges-
tion with pronase gave comparable results (not shown).903 Corinti et al.
ganic phase (data not shown). The hydrophilic fraction was
separated using centrifugal concentrators with cutoff of 10
and 3 kD. The biological activity was recovered in the fil-
trate of the 10-kD concentrator and was partially retained
in the 3-kD concentrator. The 3-kD filtrate was further
fractionated on an rpHPLC by elution with a gradient of
methanol in water (Fig. 4 A). As expected, the material
with biological activity eluted very early while most of the
contaminating compounds still present in the 3-kD filtrate
were retained by the column and were eluted at later time
points (Fig. 4 B and data not shown). The positive fraction
was z20-fold more active on a weight basis than the start-
ing material (Fig. 4 B, inset). When this fraction was ana-
lyzed by GC-MS, the chromatographic elution and the
mass spectrum revealed the presence of glucose and galac-
tose at a molar ratio of 47:53 (Fig. 4 C). Furthermore, the
same fraction contained no detectable peptides as assayed
by the Bradford method (17), direct and reverse-phase
TLC of the hydrolyzed fraction (HCl 6 N, 1108C, 6 h) fol-
lowed by ninidrin staining, Edman degradation, and amino
acid analysis using a 494 protein sequencer (data not
shown). To further exclude any peptide contamination, the
active fraction was digested with carboxypeptidase Y, a
protease which digests most peptides including those with
blocked NH2 termini (27). This treatment did not affect
the bioactivity of the purified antigen but completely abol-
ished the ability of a tetanus toxoid peptide to stimulate a
specific CD41 T cell clone (data not shown). Taken to-
gether the above results suggest that, according to two dif-
ferent criteria (i.e., sensitivity to chemical treatment and
purification with two methods), the antigen recognized by
CD81 clones is a low mol wt polyhydrate molecule, possi-
bly a carbohydrate.
APC-dependent and MHC- and CD1-independent Presenta-
tion of PjCHOAg to CD81 T Cell Clones. The requirements
for antigen recognition were studied using as readout T cell
proliferation and cytokine production. The CD81 clones
proliferated in response to PjE only in the presence of APC
(Fig. 5 A). Optimal presentation was provided by B-LCL
and PBMCs, while, surprisingly, DCs were considerably
less efficient (Fig. 5, A, and B). Several unrelated B-LCL
tested were able to function as APCs for the CD81 clones
(Fig. 5 A), even if they lacked class I (221 and C1R) or
class II molecules (SJO and T2) (Fig. 5 C). In addition, an-
tibodies to class I and class II molecules did not inhibit T
cell activation (Fig. 5 D), while they did inhibit antigen
recognition by class I– and class II–restricted T cell clones
(data not shown). A contribution of CD1 molecules was
also ruled out by the finding that (a) anti-CD1 antibodies
did not affect the proliferative response and (b) CD1-a, -b,
and -c transfectants were as efficient as the untransfected
control (data not shown). Taken together, these data sug-
gest that none of the known antigen-presenting molecules
are involved in the presentation of PjCHOAg to CD81 a/b
T cell clones.
The requirements for antigen uptake and processing
were studied using [Ca21]i increase as a sensitive and rapid
assay of T cell antigen recognition. No response was ob-
served when the CD81 T cells were incubated with the
antigen in solution, confirming the requirements for APCs
(Fig. 6 D). In contrast, the clones showed a strong and sus-
tained [Ca21]i increase when conjugated with PjE-pulsed
APC. Indeed, a time course of antigen pulsing revealed
that a short incubation with antigen (1 h) was not sufficient
for presentation (Fig. 6 B) and that the stimulatory capacity
was progressively acquired during the next 5 h of incuba-
tion (Fig. 6 C). While APC fixed after antigen pulse re-
tained the ability to induce [Ca21]i increase in T cell clones
(data not shown), APC fixed before a 5-h pulse at 378C
with PjE were ineffective (Fig. 6 E). In addition, live APC
pulsed at 158C failed to stimulate T cells (Fig. 6 F). Inter-
estingly, chloroquine did not inhibit presentation of PjCHOAg
(data not shown), suggesting that processing in an acidic
Figure 3. Oxidation with periodic acid and treatment with TFMS
completely abolished recognition of PjE by CD81 T cell clones. CD81 T
cell clones P4.2 (A) and CP.68 (C and E) and CD41 T cell clones P6.2
(B) and CP.39 (D and F) were cultured with autologous irradiated B-LCL
in the presence of different concentration of PjE (h), TFMSPjE (d), or SPPjE
(j). Proliferative responses were measured on day 3. A mock control
without periodate gave comparable results as PjE (data not shown).904 MHC-independent Recognition of a Pollen Antigen by a/b T Cells
compartment was not involved. Finally, APC retained the
capacity to stimulate T cells after removal of the antigen
(Fig. 6, G–I). By comparing the stimulatory capacity of
APC chased for different times with that of APC pulsed
with different concentrations of antigen, we estimated the
half-life of antigen on pulsed APC to be z1 h. Taken to-
gether these results suggest that PjCHOAg has to be captured
by the APC and it is displayed on their surface in a stable
Figure 4. Purification of the antigen recognized by CD81 T cell clones by rpHPLC. (A) The sample recovered after phase fractionation and ultrafiltra-
tion was separated on an rpHPLC by eluting with a linear gradient of methanol in water starting at fraction 10 (flow 0.8 ml/min). 1-ml fractions were
collected and tested for activity in T cell proliferation assay. Shown is the first 20-min profile; the dotted line represents the methanol gradient. Note that
most of the material retained on the column eluted at later time points which are not shown. (B) Proliferative response of clone P4.26 to rpHPLC frac-
tions in the presence of autologous B-LCL. Fractions 21–60 were inactive (not shown). The inset shows the titration of fraction 2 (d) compared to the
starting material PjE (h) in proliferation assay. (C and D) Sugar composition of fraction 2 (C) was determined by GC-MS and compared to a standard
mixtures of sugars (D). Glc, glucose; Gal, galactose.
Figure 5. PjCHOAg is more efficiently presented to CD81 T cells clone
by B-LCL than DCs and its presentation does not require MHC class I or
class II molecules. Proliferative response of CD81 T cell clone P4.2 (A)
and CD41 T cell clone P6.2 (B) to different concentrations of PjE in the
absence of APC (n) or in the presence of autologous B-LCL (h), MHC-
unrelated B-LCL (j), or DC (s). (C) IFN-g production by the CD81 T
cell clone P4.2 in response to PjE in the presence of autologous B-LCL
(h), T2 (m), or 221 (d) cells. Similar results were obtained using C1R
and SJO cells, which lack class I and class II molecules, respectively. (D)
Proliferative response of CD81 T cell clone P4.2 to PjE in the absence
(h) or in the presence of mAbs to HLA-class I (n), HLA-DR (,),
HLA-DQ (s), or HLA-DP (,) molecules.905 Corinti et al.
fashion, possibly associated with molecules preferentially
expressed on B cells.
TCR-b Usage and Evidence for the Involvement of TCR in the
Recognition of PjCHOAg. All CD81 PjCHOAg-specific T cell
clones isolated from two individuals express the Vb8 chain
as detected by mAbs. This finding is compatible with stim-
ulation by a Vb8-specific superantigen possibly present in
the allergenic extract. However, this possibility was ruled
out by the finding that polyclonal Vb81 lines were not
stimulated by PjE (data not shown). Since we could ex-
clude a superantigen type of recognition we searched for a
conserved motif in the CDR3 region (Table 2). Sequenc-
ing of the Vb chains of six independent T cell clones re-
vealed a remarkable conservation in positions 3 and 5 of
the CDR3 region (threonine and valine, respectively),
while the length differed by only one amino acid. In addi-
tion, all six clones analyzed used the Jb1.2 segment. We also
investigated the kinetics of T cell activation by PjCHOAg.
As shown in Fig. 7, CD81 T cells exposed to PjE-pulsed
APC undergo a [Ca21]i increase that is sustained for .30
min (Fig. 7 A) and downregulate their TCRs in an antigen
dose– and time-dependent fashion (Fig. 7 B and data not
shown). These results demonstrate that PjCHOAg triggers
the TCR with the same kinetics as conventional TCR
ligands such as peptide–MHC complexes.
Discussion
We have shown that CD81 a/b T cells can specifically
recognize a carbohydrate antigen present in a pollen ex-
tract. This antigen differs from other nonpeptide antigens
(2–7, 28) because of its chemical nature and the lack of
MHC or CD1 restriction.
Several lines of evidence suggest that the stimulatory
ligand is a carbohydrate. First, it is resistant to treatments
that destroy proteins, such as proteinase K digestion and al-
kaline treatment, excluding a possible contribution of a
peptide. Second, it separates in the aqueous phase, ruling
out the possibility that it may contain lipids. Third, it is
sensitive to agents that destroy polysaccharides, such as
Figure 6. Conditions required
for pulsing APC with PjCHOAg.
[Ca21]i in T cells (clone P4.2)
was measured in the presence of:
(A) unpulsed APC; (B and C)
APC pulsed at 378C with NaOHPjE
for 1 h (B), or 5 h (C); (D) NaOHPjE
in solution; (E) fixed APC pulsed
at 378C with NaOHPjE for 5 h; (F)
APC pulsed at 158C with NaOHPjE
for 5 h; (G–I) APC pulsed over-
night with NaOHPjE, washed, and
chased for 0 (G), 1 (H), or 4 (I) h.
Comparable results were ob-
tained using PjE as antigen. In a
separate experiment we found
that the magnitude of [Ca21]i in-
crease induced by PjE is compa-
rable to that induced by cross-
linked anti-CD3 (data not shown).906 MHC-independent Recognition of a Pollen Antigen by a/b T Cells
TFMS and periodic acid. Finally, it is enriched in a fraction
containing high levels of glucose and galactose. However,
we cannot exclude that other polyhydrate molecules with
similar sensitivity to chemical treatments may be responsi-
ble for the stimulation of PjCHOAg-specific T cell clones.
Although the structure of the epitope still has to be de-
fined, it is likely to be intracellularly generated since we
have found that, in order to stimulate specific T cells,
PjCHOAg has to be pulsed with live APC for .1 h. Indeed,
fixed APC or APC pulsed at 158C were both unable to in-
duce T cell response. We have found that chloroquine does
not interfere with presentation of PjCHOAg, suggesting that
either processing of this antigen is not required or may in-
volve a different intracellular compartment. More evidence
is needed to elucidate these points.
A remarkable finding is that recognition of PjCHOAg, un-
like recognition of other ligands by a/b T cells, does not
require the expression of classical MHC class I, class II, and
CD1 molecules. However, once generated the epitope re-
mains associated with the cell surface with a half life of z1 h.
We envisage two possibilities to explain how this epitope is
displayed on APC surface for T cell recognition. First, the
antigen may form a complex with a nonpolymorphic mol-
ecule which functions as classical antigen-presenting mole-
cules, i.e., which bind antigen and interact with TCR.
Second, PjCHOAg may be directly displayed on the cell
membrane alone or in association with an antigen-binding
molecule that serves only to concentrate the antigen but
does not interact with TCR. Interestingly, DCs, which are
the most efficient APC for protein antigens (29), are rather
ineffective in presenting PjCHOAg, suggesting that they may
lack this putative antigen-presenting/binding molecule.
Recognition of PjCHOAg by CD81 T cell clones is medi-
ated via TCR as shown by the kinetics of TCR triggering
which is comparable to that of conventional TCR ligands
such as peptide–MHC complexes (30). Moreover the pres-
ence of a conserved motif in the CDR3 region of the Vb
chain suggests the existence of a precise structural require-
Table 2. Nucleotide and Predicted Amino Acid Sequences of TCR-b Chains from PjCHO Ag-specific CD81 T Cell Clones from
Two Different Donors
Clone Vb CDR3 Jb
Donor A
P4.2 8 C A S S P G T G V D G  Y T F 1.2
tgtgccagtagtcctgggacaggggtggatggctacaccttc
Db1
P4.17 8 C A  S S L V T G V T D  G Y T F 1.2
tgtgccagtagtttggtaacaggcgtgacagatggctacaccttc
P4.52 8 C A S S Q A T A V N G Y T F 1.2
tgtgccagtagtcaagccacagcggtgaacggctacaccttc
Donor B
CP.31 8 C A  S S V A T A V T C G Y T F 1.2
tgtgccagtagtgtcgccacagcggtgacatgcgcctacacgttc
CP.38 8 C A  S S G T S V A M G Y T F 1.2
tgtgccagtagtgggacagatgtggccatgggttacaccttc
Db1
CP.68 8 C A  S S V A T A V T D G Y T F 1.2
tgtgccagtagtgtcgccacagcggtgacagatggctacaccttc
CDR3 regions run from the consensus cysteine to the first phenylanaline of the “FGXT” motif found in the J region. Identity of Db segments was
assigned when at least six consecutive bases identical to those of a germline Db segment were identified within the junctional region.
Figure 7. PjCHOAg triggers the TCR as conventional TCR ligand. (A)
Time course of [Ca21]i increase in T cell clone P4.2 conjugated with PjE-
pulsed B-LCL. (B) TCR downregulation in T cells conjugated with un-
pulsed APC or PjE-pulsed APC.907 Corinti et al.
ment for PjCHOAg recognition (30). This result, together
with the fact that polyclonal Vb81 lines do not respond to
PjCHOAg, rules out the possibility that PjCHOAg may act as a
superantigen.
The finding that CD81 T cell clones could be isolated
from both atopic patients and from healthy donors is not
surprising since they both are naturally exposed to this en-
vironmental allergen (31). However, it is interesting that
only the clones from the atopic patient produce high levels
of IL-4 and IL-5 and express CD40L , suggesting that these
CD81 cells may have undergone a Th2-like polarization in
vivo (32, 33). The functional significance of these CD81 T
cells in allergy remains a matter of speculation (34). It is
possible that these cells may participate in the production of
IL-4 thus influencing the differentiation of naive allergen-
specific T cells towards Th2 (35–37). In addition, the re-
quirement for processing and the stability of the epitope
suggest the possibility that CD81 PjCHOAg-specific T cell
clones may function as typical carrier-specific T cells. Inter-
estingly, these clones are not cytotoxic (Sallusto, F., un-
published data) and may thus provide cognate help to anti-
gen-specific B lymphocytes. If this is a general case, the
polarization of the specific CD81 cells towards help or cy-
totoxicity may become a critical factor controlling the
stimulation of an IgE response or its suppression (38, 39).
These results suggest that the response to carbohydrate
antigens may be part of the normal response to environ-
mental allergens and that this response can be polarized in
atopic patients. Polysaccharides are generally considered
typical T-independent antigens. However, T cells that
modulate responses to polysaccharides have been observed
in several systems (40–46). Our results might explain these
earlier observations and raise the possibility that T cell rec-
ognition of carbohydrates may play a role in the immune
response.
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